Press Releases

International Expert-Consensus
Fighting nerve damage together 
An international expert panel published recommendations for diagnosis and management of diabetic neuropathy. Wörwag Pharma provides information on the current consensus recommendations for health care professionals.
Wörwag Pharma invests in own production
Böblingen, February 17th, 2022 – The Boeblingen-based family-owned company Wörwag Pharma invested in several strategic milestones in 2021 and successfully closed the year with a year-on-year increase in sales to 269.9 million euros. The signs continue to focus on investment and growth.
Fritz-Wörwag-Research-Prize 2021
Fritz-Wörwag-Research-Prize: New scientific findings from biofactor research honored
In order to support science and research, Wörwag Pharma has awarded the 10th Fritz Wörwag Research Prize this year. The prize rewards new research findings in the field of biofactors – this year on “Biofactors in diabetes and its comorbidities“.
Wörwag Pharma-Logo
With new company logo into the next 50 years
Just in time for the anniversary year, Wörwag Pharma presents itself with a new logo: traditional yet innovative, rooted yet globally oriented.
Sensilab site near Lódz
Wörwag Pharma acquires production company in Poland
Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and development service provider of pharmaceuticals, in Lódz, Poland. For the first time in the 50-year history, the family-owned company is investing in its own production facility - a decisive milestone for future growth.
Lucia Cinque
Lucia Cinque appointed additional managing director
Wörwag Pharma announces that Lucia Cinque will join the company as Managing Director on June 1, 2021. In the newly created role of Chief Innovation Officer (CINO), she will lead the company together with Jochen Schlindwein, CEO, and Gerhard Mayer, CFO.
Positive development worldwide - Woerwag Pharma invests in the future
Despite the challenges of the Corona year, the family-owned company Woerwag Pharma successfully closes 2020 with a year-on-year increase in sales to 235.8 million euros. Despite Corona, the signs are set for investment and growth.
Monika Wörwag
Change in management
After almost twenty years at the head of Woerwag Pharma GmbH & Co. KG, Monika Woerwag will step down from the management board effective on January 1, 2021. However, she will remain with the company in a management position.

Press Contact

Kerstin Imbery-Will
Kerstin Imbery-WillPublic relations+49 4183 774623kerstin.imbery-will@woerwagpharma.com
Monika Wörwag
Monika WörwagCompany Communicationsmonika.woerwag@woerwagpharma.com